IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells

[Roles of Newcastle disease virus in human acute monocytic leukemia in vitro and in vivo]

Oncolytic virus-initiated protective immunity against prostate cancer

Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity

Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25

Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer

Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine

Use of attenuated paramyxoviruses for cancer therapy

Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma

The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination